Hyperion Therapeutics (HPTX) Worth Watching: Stock Up 6.3% - Tale of the Tape

Hyperion Therapeutics, Inc. (HPTX) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 37% in the past one-month time frame.

This biopharmaceutical company has seen three positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This suggests solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Hyperion Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Investors interested in the Med-Drugs industry may also consider Lannett Company, Inc. (LCI) that sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
HYPERION THERAP (HPTX): Free Stock Analysis Report
 
LANNETT INC (LCI): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement